Table 2.

Summary of copy number change in 30 myeloma samples, split into the three groups: t(4;14), t(11;14), and HRD



Gain

Loss
Chromosome
t(4;14)
t(11;14)
HRD
χ2(P)
t(4;14)
t(11;14)
HRD
χ2(P)
1   +1q [5]   +1q [1]   +1q [5]   8.15 (.025)   –1p [5]   –1p [1]   –1p [1]   11.1 (.01)  
2   –   –   +2 [1]   1.78 (NS)   –   –2p [1]   –   1.46 (NS)  
3   +3 [2], +3q [1]   –   +3 [7]   10.8 (.01)   –   –   –   –  
4   +4 [1]   +4 [1]   +4 [1]   0.19 (NS)   –4 [1]   –   –   3.4 (NS)  
5   +5 [2]   –   +5 [5]   6.7 (.05)   –   –   –   –  
6   +6 [1], +6p [1]   –   +6p [3]   4.0 (NS)   –6q [1]   –6q [2]   –6q [1]   0.29 (NS)  
7   +7 [1], +7q [1]   –   +7 [5]   6.7 (.05)   –   –   –   –  
8   –   –   +8q [1]   1.78 (NS)   –8p [2]   –8p [1], –8q [1]   –8p [6]   5.84 (NS)  
9   +9 [1]   +9q [1]   +9 [8]   12.2 (.01)   –9p [1]   –   –   3.39 (NS)  
10   –   –   –   –   –   –   –   –  
11   +11 [1]   +11q [3]   +11 [7], +11q [1]   7.9 (.025)   –11q [1]   –   –   3.39 (NS)  
12   –   –   –   –   –12p [2], –12p [1]   –   –   7 (.05)  
13   –   –   –   –   –13 [7]   –13 [6]   –13 [2]   11.45 (.01)  
14   –   –   –   –   –14q [2]   –   –   7.0 (.05)  
15   +15 [4]   –   +15 [9]   16.35 (.001)   –   –   –   –  
16   –   –   –   –   –   –16p [1], –16q [4]   –16q [2]   3.0 (NS)  
17   –   –   +17 [1], +17p [1]   3.7 (.2)   –17q [1]   –17p [2]   –17q [1]   3.2 (NS)  
18   –   +18 [1]   +18 [1]   0.67 (NS)   –   –   –   –  
19   +19 [3]   +19 [3]   +19 [11]   13.85 (.01)   –   –   –   –  
20   –   –   +20 [1]   1.7 (NS)   –20p [1]   –   –   3.39 (NS)  
21   +21 [1]   –   –   3.39 (NS)   –21q [1]   –   –   3.39 (NS)  
22   –   –   –   –   –22q [2]   –22q [1]   –22q [1]   1.87 (NS)  
X
 
+Xq [1]
 
+Xq [1]
 
+Xq [1]
 
0.18 (NS)
 
–X [3]
 
–X [5]
 
–X [2]
 
1.79 (NS)
 


Gain

Loss
Chromosome
t(4;14)
t(11;14)
HRD
χ2(P)
t(4;14)
t(11;14)
HRD
χ2(P)
1   +1q [5]   +1q [1]   +1q [5]   8.15 (.025)   –1p [5]   –1p [1]   –1p [1]   11.1 (.01)  
2   –   –   +2 [1]   1.78 (NS)   –   –2p [1]   –   1.46 (NS)  
3   +3 [2], +3q [1]   –   +3 [7]   10.8 (.01)   –   –   –   –  
4   +4 [1]   +4 [1]   +4 [1]   0.19 (NS)   –4 [1]   –   –   3.4 (NS)  
5   +5 [2]   –   +5 [5]   6.7 (.05)   –   –   –   –  
6   +6 [1], +6p [1]   –   +6p [3]   4.0 (NS)   –6q [1]   –6q [2]   –6q [1]   0.29 (NS)  
7   +7 [1], +7q [1]   –   +7 [5]   6.7 (.05)   –   –   –   –  
8   –   –   +8q [1]   1.78 (NS)   –8p [2]   –8p [1], –8q [1]   –8p [6]   5.84 (NS)  
9   +9 [1]   +9q [1]   +9 [8]   12.2 (.01)   –9p [1]   –   –   3.39 (NS)  
10   –   –   –   –   –   –   –   –  
11   +11 [1]   +11q [3]   +11 [7], +11q [1]   7.9 (.025)   –11q [1]   –   –   3.39 (NS)  
12   –   –   –   –   –12p [2], –12p [1]   –   –   7 (.05)  
13   –   –   –   –   –13 [7]   –13 [6]   –13 [2]   11.45 (.01)  
14   –   –   –   –   –14q [2]   –   –   7.0 (.05)  
15   +15 [4]   –   +15 [9]   16.35 (.001)   –   –   –   –  
16   –   –   –   –   –   –16p [1], –16q [4]   –16q [2]   3.0 (NS)  
17   –   –   +17 [1], +17p [1]   3.7 (.2)   –17q [1]   –17p [2]   –17q [1]   3.2 (NS)  
18   –   +18 [1]   +18 [1]   0.67 (NS)   –   –   –   –  
19   +19 [3]   +19 [3]   +19 [11]   13.85 (.01)   –   –   –   –  
20   –   –   +20 [1]   1.7 (NS)   –20p [1]   –   –   3.39 (NS)  
21   +21 [1]   –   –   3.39 (NS)   –21q [1]   –   –   3.39 (NS)  
22   –   –   –   –   –22q [2]   –22q [1]   –22q [1]   1.87 (NS)  
X
 
+Xq [1]
 
+Xq [1]
 
+Xq [1]
 
0.18 (NS)
 
–X [3]
 
–X [5]
 
–X [2]
 
1.79 (NS)
 

Only large regions of chromosomal gain and loss are indicated, with numbers of cases in square brackets. χ2 performed: for significance at P < .05 level, χ2 result should be greater than 5.99. For t(4;14), n = 7; for t(11;14), n = 12; and for HRD, n = 11

HRD indicates hyperdiploid; –, no change; NS, not significant

Close Modal

or Create an Account

Close Modal
Close Modal